( May 1, 2025, 9:46 AM EDT) -- NEW YORK — The U.S. Attorney’s Office for the Southern District of New York announced that Gilead Sciences Inc. agreed to pay $202 million to settle a suit against it alleging that Gilead violated the False Claims Act (FCA) by paying remuneration to health care practitioners who spoke at Gilead speaker events to induce them to prescribe Gilead HIV drugs and causing false claims to be submitted to government insurers....